Navigation Links
Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jun 4, 2007 - Acorda Therapeutics, Inc.(R) (Nasdaq: ACOR) today announced that the Company presented a "meta-analysis" or combined analysis of two clinical trials of Fampridine-SR in multiple sclerosis during a poster session at the Americas Committee for Treatment and Research in MS (ACTRIMS) Meeting in Washington, D.C. on Saturday, June 2, 2007. The poster, "Validation of Consistent Improvement in Walking Speed on the Timed 25 Foot Walk as a Measure of Clinically Meaningful Change," was presented by Andrew Goodman, M.D., Director of the Multiple Sclerosis Center at the University of Rochester.

The objective of the analysis was to validate a consistent response criterion as a measure of clinically meaningful change. A consistent timed walk responder was defined as a subject whose walking speeds for at least three of the four on-treatment visits were faster than the fastest speed across any of their five non-treatment visits. In both studies, Fampridine-SR treatment was associated with significantly increased probability of this response compared to placebo (p less than 0.001). Both clinical trials were double-blind, placebo-controlled, parallel group, multi-center studies. The analysis was designed after the data from the first study were available. A total of 501 patients were included in the analysis.

The clinical meaningfulness of this response criterion was assessed primarily by use of the 12-Item MS Walking Scale (MSWS-12), a questionnaire in which the patient rates the clinical impact of his or her walking disability on activities of daily life. Additional criteria for clinical meaningfulness included a seven-point Subject Global Impression (SGI) and a seven-point Clinician Global Impression (CGI). In the meta-analysis, timed-walk responders had significantly greater average improvements from baseline in the MSWS-12 score than the non-responders in both studies in
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
2. Acorda Therapeutics to Host Analyst and Investor Reception
3. Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data Selected for Scientific Highlights Program at the American Academy of Neurology Meeting
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Acorda Therapeutics Presents Fampridine Data ACTRIMS Meeting
(Date:8/29/2014)... NEW YORK , Aug. 29, 2014 ... EDAP TMS S.A. ("EDAP" or the "Company") (NASDAQ: ... action, filed in United States District Court, Southern District ... under 14-cv-6069, is on behalf of a class consisting ... between February 1, 2013 and July 30, 2014, inclusive ...
(Date:8/29/2014)... WEST JORDAN, Utah , Aug. 29, 2014 /PRNewswire/ ... Imaging Solutions, has acquired Polaris Medical Imaging, a leader ... CT scanners. This strategic acquisition allows BC Technical to ... their capabilities, specifically within MR and CT modalities. ... lower cost service," said Mark Alvarez , president ...
(Date:8/29/2014)... Does your doctor know what you,re smoking?  Chances ... marijuana to the over 112,000 currently registered patients under ... the other roughly 20,300+ active physicians listed with the Colorado ... – even though a poll in February 2014 showed 51% ... tried it. "With marijuana legalization underway, every ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3BC Technical Acquires Polaris Medical Imaging 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... of the Creighton University School of Medicine presented a ... of Clinical Oncology (ASCO) Annual Symposium, June 5th in ... in Gynecologic Cancer Detected by an In Vitro Assay, ... Drug Response Marker test results taken in the primary ...
... Ill., June 6, 2011 As part of its ... misuse, and diversion of prescription medications, the National Association ... the NABP PMP InterConnect. NABP will now focus on ... and their software vendors to finalize the software interface, ...
Cached Medicine Technology:Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cancers 2NABP PMP InterConnect Development Complete; PMPs Continue to Sign on to Participate in National System for Tracking Drug Abuse and Diversion 2
(Date:8/30/2014)... (PRWEB) August 30, 2014 According to ... a decision that requires Takeda Pharmaceutical Co. and Eli ... damages for claims that the drugmakers concealed information about ... medication Actos. The case, Allen v. Takeda Pharmaceuticals North ... Court, Western District of Louisiana (Lafayette).* , According to ...
(Date:8/30/2014)... Hands On Mobile Massage and ... complete spa experience combining elegant decor, soothing music, ... important ingredient of all, states Marla Kaplan-Pelle, Director ... will enjoy the get-away feel, without leaving the ... "Step into the spacious, luxurious spa and leave ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The Plastic ... in New Jersey and even in the U.S. to ... takes inches off of patients’ waists with deep-tissue heating. ... in small sections, Vanquish is more inclusive to target ... Patients lay comfortably under panels about one inch away ...
(Date:8/30/2014)... After offering hyperbaric oxygen therapy ... past several years, Dr. Roy Schmidt and the ... a scholarship program for veterans who have been ... held this summer to discuss veterans’ needs ( ... shed light on the large number of veterans ...
(Date:8/30/2014)... Insomnia causes disturbances in every aspect of ... unknowingly developed insomnia and the steps often used to return ... in to the show at this link: Dr. Carol ... August 30, and will be podcasted at this link ... DrCarolFrancisTalkRadio.com. , "Insomnia causes countless unrecognized complications. ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2Health News:Hands On Mobile Massage and Spa of Long Island Now Offers a Spa-on-wheels 2Health News:NJ Top Docs Presents, The Plastic Surgery Group 2Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2
... developments regarding,North Carolina,s organ and tissue donation protocol ... hire Corder Philips to aid in the,campaign to ... include a grant received from the License to ... their online,registry and increase outreach efforts by allowing ...
... Members ... -, ... Education Coalition,s Supporting the Children of the,National Guard and Reserve Institute (GRI) ... Emergency,Assistance Fund. The contribution will help support the needs of more than,8,300 ...
... DEERFIELD, IL, Dec. 11 /PRNewswire-FirstCall/ - Cardiome,Pharma Corp. ... partner,Astellas Pharma US, Inc. ("Astellas") today announced that ... U.S. Food and Drug,Administration (FDA) has recommended that ... hydrochloride, an investigational,new drug for rapid conversion of ...
... feelings, study shows , TUESDAY, Dec. 11 (HealthDay ... of the brain, says a University of California, Los ... of Neurology . , The study included 14 adults ... imaging (fMRI) while they evaluated a series of statements ...
... have identified a genetic variant of the DAB2IP ... aggressive prostate cancer. Research teams from the Translational ... of Medicine, the Karolinska Institute in Stockholm, Sweden, ... jointly. , Researchers suspect that the DAB2IP gene ...
... small islands of genes within the human genome is a ... DNA is junk, some of it is used to help ... in Genome Research, Hopkins researchers have now found that this ... to inherited diseases like Parkinsons or mental disorders, may be ...
Cached Medicine News:Health News:North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign 2Health News:TriWest Contributes $25,000 to Washington National Guard Fund and Sponsors Education for Teachers of Military Children 2Health News:FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation 2Health News:FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation 3Health News:FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation 4Health News:FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation 5Health News:FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation 6Health News:Personal Convictions May Control Both Behavior and Emotions 2Health News:Study finds gene linked to aggressive prostate cancer 2Health News:Study finds gene linked to aggressive prostate cancer 3Health News:More 'functional' DNA in genome than previously thought 2
... Thru-the-Lens Headlight Video Camera System ... Source. Provides surgeon's eye view ... or edit tapes or digital files ... sharp focus from 8" to 36". ...
... automated system that enables you to perform ... hemostatic disordersincluding D-Dimer, Von Willebrand Antigen and ... rerun testing for greater efficiency in your ... service to help your lab increase uptime ...
... Studies have shown that the best, least ... to warm the OR to 72-75 degrees, eliminating ... operating room, though, can cause the surgical team ... can help keep surgeons cool regardless of OR ...
... Embolic Protection System is designed to provide ... when performing carotid stenting interventions. The ACCUNET ... system that utilizes rapid exchange technology so ... filter during catheter manipulations. It is available ...
Medicine Products: